Literature DB >> 16175570

Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons.

Karla Hernández-Fonseca1, Lourdes Massieu.   

Abstract

Disturbances in neuronal calcium homeostasis have been implicated in a variety of neuropathological conditions, including cerebral ischemia, hypoglycemia, and epilepsy, and possibly constitute part of the cell death process associated with chronic neurodegenerative disorders. We investigated if endoplasmic reticulum (ER) calcium stores participate in neuronal death triggered by moderate glycolysis inhibition induced by iodoacetate, an inhibitor of glyceraldehyde-3-phosphate dehydrogenase, in cultured hippocampal neurons. Results show that exposure to iodoacetate leads to a slow partial decrease in cell survival, which is significantly prevented in the absence of Ca(2+) or in the presence of the calcium chelator BAPTA-AM. Treatment with caffeine and a low (1 microM) concentration of ryanodine, which activates the ryanodine receptor (RyR), exacerbates neuronal death, whereas dantrolene and 25 microM ryanodine, which antagonizes RyR, prevents damage. Xestospongin C (XeC), an antagonist of the inositol-3-phosphate (IP(3)) receptor (IP(3)R) also prevents neuronal damage. Inhibitors of the ER calcium ATPase (sarcoendoplasmic reticulum Ca(2+) ATPase; SERCA) have no effect. The decrease in ATP levels induced by iodoacetate is potentiated by caffeine and prevented by dantrolene. Although only a slight increase in glutamate extracellular levels is observed 3.5 hr after iodoacetate exposure, the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, MK-801, efficiently prevents neuronal damage. Taken together, the data suggest that neuronal death induced during moderate glycolysis inhibition involves calcium influx through NMDA receptors and calcium release from intracellular ER stores. These results might be relevant to the understanding the mechanisms involved in neuronal damage related to aging and chronic neurodegenerative diseases, which have been associated with decreased glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175570     DOI: 10.1002/jnr.20631

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  20 in total

Review 1.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

2.  D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo.

Authors:  Jana Mejía-Toiber; Teresa Montiel; Lourdes Massieu
Journal:  Neurochem Res       Date:  2006-11-18       Impact factor: 3.996

3.  The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.

Authors:  Agnieszka Magrys; Thimmappa Anekonda; Gaoying Ren; Grazyna Adamus
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

Review 4.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

5.  Dantrolene inhibits the calcium plateau and prevents the development of spontaneous recurrent epileptiform discharges following in vitro status epilepticus.

Authors:  Nisha Nagarkatti; Laxmikant S Deshpande; Dawn S Carter; Robert J DeLorenzo
Journal:  Eur J Neurosci       Date:  2010-06-28       Impact factor: 3.386

6.  Spatiotemporal analysis of purkinje cell degeneration relative to parasagittal expression domains in a model of neonatal viral infection.

Authors:  Brent L Williams; Kavitha Yaddanapudi; Mady Hornig; W Ian Lipkin
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

7.  Palmitic Acid-Induced NAD+ Depletion is Associated with the Reduced Function of SIRT1 and Increased Expression of BACE1 in Hippocampal Neurons.

Authors:  Manuel Flores-León; Martha Pérez-Domínguez; Rodrigo González-Barrios; Clorinda Arias
Journal:  Neurochem Res       Date:  2019-05-09       Impact factor: 3.996

8.  Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington's disease mice.

Authors:  Ana María Estrada-Sánchez; Teresa Montiel; Lourdes Massieu
Journal:  Neurochem Res       Date:  2010-04-18       Impact factor: 3.996

9.  Pharmacologic intervention targeting glycolytic-related pathways protects against retinal injury due to ischemia and reperfusion.

Authors:  Ling Zheng; Shuqing Liu; Ming-Zhong Sun; Jinsook Chang; Mark R Chance; Timothy S Kern
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

10.  Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.

Authors:  Octavio Mercado-Gómez; Karla Hernández-Fonseca; Alexa Villavicencio-Queijeiro; Lourdes Massieu; Jesús Chimal-Monroy; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.